Status:
UNKNOWN
Cognitive-behavioral Treatment for Rheumatoid Arthritis
Lead Sponsor:
Chengdu PLA General Hospital
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
To evaluate the effectiveness of Cognitive-behavioral treatment for people with rheumatoid arthritis
Eligibility Criteria
Inclusion
- diagnosed by rheumatology consultants with RA
Exclusion
- severe psychological difficulties
- currently receiving mental health care
- any medical condition that might prevent them from safely exercising (e.g. history of more severe heart, lung or cerebrovascular disease)
- previously attended an education programme
- had a Modified Health Assessment Questionnaire score \>2 (score range 0-3), that is severe functional problems
- history of organic brain syndrome
- presence of a psychotic disorder
- presence of other uncontrolled medical disorders
- presence of a major communication disorder, illiteracy
- presence of less than an 8th grade education (due to inability to complete questionnaires)
- presence of a therapeutic dosage of an antidepressant medication, or presence of another autoimmune disease/disabling condition
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT02257073
Start Date
October 1 2014
End Date
July 1 2020
Last Update
April 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Chengdu Military Area Command PLA
Chengdu, Sichuan, China, 610083